Diabetology & Metabolic Syndrome

Papers
(The H4-Index of Diabetology & Metabolic Syndrome is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
GRP78 protein metabolism in obese and diabetic rats: a study of its role in metabolic disorders136
Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b115
A review of reusable insulin pens and features of TouStar—a new reusable pen with a dedicated cartridge70
MRI adipose tissue segmentation and quantification in R (RAdipoSeg)65
The association of changes in the Chinese visceral adiposity index and cardiometabolic diseases: a cohort study65
Reclassification of type 2 diabetes to type 1 diabetes in Asturias (Spain) between 2011 and 202055
Correction to: Development of models to predict 10-30-year cardiovascular disease risk using the Da Qing IGT and diabetes study55
The impact of obesity in hospitalized patients with COVID-19: a retrospective cohort study54
Investigating CR1 as an indicated Gene for mild cognitive impairment in type 2 diabetes mellitus49
Association between estimated glucose disposal rate with the all-cause and cause-specific mortality among the population with cardiometabolic syndrome49
Preclinical evidence of the effect of icariin on diabetic nephropathy: a systematic review and meta-analysis46
Association between the triglyceride–glucose index and acute kidney injury in patients undergoing percutaneous coronary: a retrospective analysis of the MIMIC-IV database45
Unveiling the role of lipopolysaccharide-related genes in diabetic retinopathy: identification of key biomarkers and immune infiltration analysis44
Chronic supplementation of noni in diabetic type 1-STZ rats: effects on glycemic levels, kidney toxicity and exercise performance42
17-year follow-up of association between telomere length and all-cause mortality, cardiovascular mortality in individuals with metabolic syndrome: results from the NHANES database prospective cohort s40
Triglyceride glucose index–body mass index as a predictor of coronary artery disease severity in patients with H-type hypertension across different glucose metabolic states39
Mesenchymal stem cells ameliorate inflammation and pyroptosis in diabetic cardiomyopathy via the miRNA-223-3p/NLRP3 pathway39
Diabetic ketoacidosis in patients with SARS-CoV-2: a systematic review and meta-analysis38
An affordable approach to classifying type 2 diabetes based on fasting plasma glucose, TyG index and BMI: a retrospective cohort study of NHANES Data from 1988 to 201438
Non-linear association of a novel inflammation-lipid composite marker CRP/HDL with insulin resistance and type 2 diabetes: findings from a comprehensive national cross-sectional study36
Metformin plus lifestyle interventions versus lifestyle interventions alone for the delay or prevention of type 2 diabetes in individuals with prediabetes: a meta-analysis of randomized controlled tri33
Association between various blood glucose variability-related indicators during early ICU admission and 28-day mortality in non-diabetic patients with sepsis33
The relationship of platelet-to-lymphocyte ratio with cognitive decline in T2DM32
Association of the stress hyperglycemia ratio with coronary artery disease complexity as assessed by the SYNTAX score in patients with acute coronary syndrome31
Correction: Semaglutide restores astrocyte-vascular interactions and blood-brain barrier integrity in a model of diet-induced metabolic syndrome30
Association of caffeine intake with all-cause and cardiovascular mortality in diabetes and prediabetes29
Plasma aryl hydrocarbon receptor associated with epicardial adipose tissue in men: a cross-sectional study28
The effect of metabolic dysfunction-associated fatty liver disease and diabetic kidney disease on the risk of hospitalization of heart failure in type 2 diabetes: a retrospective cohort study28
Nature’s blueprint for sugar metabolism: translating bee and ant strategies into human diabetes therapies28
0.080877065658569